PYFA: PT Pyridam Farma Tbk - Summary | Jitta

PT Pyridam Farma Tbk

IDN:PYFA

Price
Rp302.00
Loss Chance
58.4%
0.77JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
801 / 855
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (34)
Recent Business Performance (31)
Financial Strength (21)
Return to Shareholders (2)
Competitive Advantage (36)
Jitta Signs
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 46.12% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.77
100.00%
4.68
45.84%
4.29
428.89%
Pharmaceuticals
4.57
50.64%
3.68
133.17%
6.76
9.02%
COMPANY DESCRIPTION
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; medical support products; over the counter, ethical, and sigma products in the areas of musculo-skeletal, cardiovascular and hematopoietic system, genito urinary system, and respiratory system, as well as mineral and health supplements, vitamins, and other consumer health products in the form of syrups, tablets, and capsules; and sanitizers and antiseptics. PT Pyridam Farma Tbk was founded in 1976 and is based in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.